MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
0.1800
-0.0191
-9.59%
Pre Market: 0.1875 +0.0075 +4.17% 05:27 05/08 EDT
OPEN
0.1990
PREV CLOSE
0.1991
HIGH
0.2000
LOW
0.1700
VOLUME
500
TURNOVER
79.66K
52 WEEK HIGH
1.485
52 WEEK LOW
0.1700
MARKET CAP
15.55M
P/E (TTM)
-0.1686
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XAIR last week (0428-0502)?
Weekly Report · 3d ago
Weekly Report: what happened at XAIR last week (0421-0425)?
Weekly Report · 04/28 10:37
Beyond Air Gets Patent for Lung Infection Treatment
Dow Jones · 04/24 21:23
Beyond Air granted U.S. patent for gaseous nitric oxide delivery
TipRanks · 04/24 20:16
Beyond Air granted U.S. patent for treatment of NTM infections using gaseous Nitric Oxide
Seeking Alpha · 04/24 20:14
BEYOND AIR GRANTED U.S. PATENT COVERING TREATMENT OF NTM INFECTIONS USING GASEOUS NITRIC OXIDE (GNO)
Reuters · 04/24 20:05
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
Barchart · 04/24 15:05
NeuroNOS Receives FDA's Orphan Drug Designation For BA-102 In Treating Rare Phelan-McDermid Syndrome
NASDAQ · 04/22 01:06
More
About XAIR
More
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received United States Food and Drug Administration (FDA) approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. It is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19), and nontuberculous mycobacteria (NTM) among others. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder (ASD) and other neurological disorders. Its approved product and active pipeline of product candidates include LungFit PH, LungFit PRO and LungFit GO.
Recently
Symbol
Price
%Change

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.